Anti-Fraud Policy

Anti-Fraud Policy Statement

“The Community Blood Centers’ Exchange is 100% committed to the process of identifying and eliminating fraud in the insurance industry in general, and in the medical professional liability insurance industry in particular. BCx will therefore exercise its best efforts to

  1. Identify potential sources of fraudulent acts, both internal and external
  2. Establish policies and procedures designed to reduce the occurrence of fraudulent acts

The effectiveness of the anti-fraud policies established by the BCx board will be monitored by the Executive Director of BCx, who will report to the Board no less than annually on the procedures that exist or are recommended to protect BCx and its policyholders from fraudulent activities.

Any director, officer or committee member of BCx that becomes aware of any actual or potential fraudulent activity will be responsible for immediate reporting of such activity to the Executive Director or Executive Committee of BCx.”

Protection for individuals reporting fraud

Any reports made by individuals concerning actual or potential fraudulent acts arising from the operations of BCx will be confidential. The identity of the individual making such reports will not be disclosed except as required by law or by a court or regulatory body having jurisdiction over any investigation into the alleged fraudulent activity. BCx will not take or allow any retaliatory action against individuals that report actual or potential fraudulent acts, except if an investigation into the circumstances surrounding the report, undertaken by individuals that have no conflicts of interest that would prevent them from undertaking an objective investigation, determine that the individual or individuals making the report were motivated by a malicious desire to harm BCx, or its directors, officers, committee members, service providers or policyholders.

Contact Information for Fraud Reporting

If you become aware of any activities that you know or suspect to be fraudulent, please contact one of the following:

Chairperson of BCx

Lee Ann Weitekamp, MD, Medical Director, Michigan Blood

1036 Fuller Northeast Grand Rapids MI 49503

Phone: 616-233-8571

Vice Chairperson of BCx

John Hagins, CEO, The Community Blood Center, Inc.

4406 W Spenser Street I Appleton, WI 54914

Phone: 920-560-6626

Secretary of BCx

Marshall Cothran, CEO, We Are Blood

4300 N Lamar Blvd, Austin, TX 78756

Phone: 512-206-1251

Treasurer of BCx

Jim Decker, Executive Director, Medic, Inc.

1601 Ailor Avenue, Knoxville, TN 37921

Phone: 865-524-3074

BCx Executive Director

Eric Blomfelt

5221 Cornerstone Drive Fort Collins CO 80528

Phone: 303-800-8177